So many qualified people out there to lead this company forward. And who do we have....an overpaid lawyer. And people wonder why the stock isn't skyrocketing. Go figure.
It didn't make sense then, and it doesn't make sense now.
Let's assume any meaningful amount is converted locally for some cannabinoid component. Even though it has never been proven the magic CIABs can convert a therapeutic amount of anything in humans.
Given biotechs working on cannabinoid extracts (e.g. for pain) are reporting very low toxicity, then why are the CIABs needed? Need a higher dose of cannabinoid extract on a tumor? Just increase the oral dose of the cannabinoid extract. The liver converts, and the higher systemic dose arrives at the site, with no side effects.
Of course no biotech has shown in a CT, cannabinoids have any affect on cancer cells other than for possibly Glioblastoma. So, implant CIABs on some brain tumor vein (brain surgery), or just take a higher oral dose? Which might just be a little more easy to accomplish???
However, given weed scams are popular in OTC Microcrap stocks, it gives Kenny a good scam to PR pump in the future.